Comparative effectiveness of extended-release naltrexone versus buprenorphine-naloxone for opioid relapse prevention (X:BOT): a multicentre, open-label, randomised controlled trial

Autor: Lee, Joshua D, Nunes, Edward V, Jr, Novo, Patricia, Bachrach, Ken, Bailey, Genie L, Bhatt, Snehal, Farkas, Sarah, Fishman, Marc, Gauthier, Phoebe, Hodgkins, Candace C, King, Jacquie, Lindblad, Robert, Liu, David, Matthews, Abigail G, May, Jeanine, Peavy, K Michelle, Ross, Stephen, Salazar, Dagmar, Schkolnik, Paul, Shmueli-Blumberg, Dikla, Stablein, Don, Subramaniam, Geetha, Rotrosen, John

Publikováno v: In The Lancet 27 January-2 February 2018 391(10118):309-318

A Phase 2 Randomized, Double-Blind, Placebo-controlled Trial of Oral Camostat Mesylate for Early Treatment of COVID-19 Outpatients Showed Shorter Illness Course and Attenuation of Loss of Smell and Taste

Autor: Chupp, Geoffrey, Spichler-Moffarah, Anne, Søgaard, Ole S, Esserman, Denise, Dziura, James, Danzig, Lisa, Chaurasia, Reetika, Patra, Kailash P, Salovey, Aryeh, Nunez, Angela, May, Jeanine, Astorino, Lauren, Patel, Amisha, Halene, Stephanie, Wang, Jianhui, Hui, Pei, Patel, Prashant, Lu, Jing, Li, Fangyong, Gan, Geliang, Parziale, Stephen, Katsovich, Lily, Desir, Gary V, Vinetz, Joseph M

Publikováno v: Chupp, G, Spichler-Moffarah, A, Søgaard, O S, Esserman, D, Dziura, J, Danzig, L, Chaurasia, R, Patra, K P, Salovey, A, Nunez, A, May, J, Astorino, L, Patel, A, Halene, S, Wang, J, Hui, P, Patel, P, Lu, J, Li, F, Gan, G, Parziale, S, Katsovich, L, Desir, G V & Vinetz, J M 2022 ' A Phase 2 Randomized, Double-Blind, Placebo-controlled Trial of Oral Camostat Mesylate for Early Treatment of COVID-19 Outpatients Showed Shorter Illness Course and Attenuation of Loss of Smell and Taste ' medRxiv . https://doi.org/10.1101/2022.01.28.22270035

IMPORTANCE: Early treatment of mild SARS-CoV-2 infection might lower the risk of clinical deterioration in COVID-19.OBJECTIVE: To determine whether oral camostat mesylate would reduce upper respiratory SARS-CoV-2 viral load in newly diagnosed outpati

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pure_au_____::bf3288b3b8082d45b36216e658b7ad61
https://pure.au.dk/portal/da/publications/a-phase-2-randomized-doubleblind-placebocontrolled-trial-of-oral-camostat-mesylate-for-early-treatment-of-covid19-outpatients-showed-shorter-illness-course-and-attenuation-of-loss-of-smell-and-taste(5c14ab40-e16a-44a7-83e6-502d425100b5).html

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.